4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-292519
Chief Executive Officer sold 8,220 shares at an average $39.83 ($327,398)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X06/ownership.xml…